By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Phone: Fax:


Company News
Astellas Pharma US Release: Lancet Publishes Results From The Phase 2 TERRAIN Trial of enzalutamide Compared To bicalutamide In Metastatic Castration-Resistant Prostate Cancer 1/14/2016 7:02:52 AM
Abcodia Release: Data Published In The Lancet Suggest New Ovarian Cancer Screening Test Reduces Mortality 12/18/2015 6:50:15 AM
Astellas (ALPMY) Announces Publication Of CRESEMBA (Isavuconazonium Sulfate) Pivotal Phase 3 Study Results In The Lancet 12/10/2015 6:38:49 AM
Merrimack (MACK) And Baxalta (BXLT) Announce Publication Of The ONIVYDE (irinotecan liposome injection) NAPOLI-1 Study In The Lancet 11/23/2015 6:39:29 AM
PharmaEngine, Inc. Announces The Lancet Publication Of The ONIVYDE Phase 3 NAPOLI-1 Study 11/23/2015 6:26:11 AM
Maternal Mortality Falls By Almost 50%, Lancet Publishes 11/12/2015 7:14:34 AM
St. Jude Medical (STJ) Release: New Long-Term Data Published In The Lancet Further Demonstrates Superiority Of The Cardiomems HF System Over Standard Of Care 11/9/2015 10:58:46 AM
Elekta Release: Phase III Data Published in The Lancet Show Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy Is Clinically Equivalent To Whole Breast Irradiation In Early Stage Cancer 10/20/2015 10:16:40 AM
Results From Merck & Co. (MRK)’s Phase 3 Study Of Investigational Chronic Hepatitis C Therapy Elbasvir/Grazoprevir In Patients With Advanced Chronic Kidney Disease Published In Lancet 10/6/2015 12:01:00 PM
Inovio Pharma (INO) Publishes Successful Phase 2b Trial Results Of Its HPV Immunotherapy In The Lancet Lancet 9/17/2015 6:17:27 AM